Aratana Therapeutics (PETX) IPO Prices at $6/Share
Tweet
Share
E-mailGet Alerts PETX Hot Sheet
Join SI Premium – FREE
Aratana Therapeutics (NASDAQ: PETX) priced its 5,750,000 share IPO at $6 per share, in-line with the expected pricing. Shares will open on the NASDAQ today at approximately 11:20AM ET on the NASDAQ under the symbole "PTEX."
Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum Capital Group are acting as co-managers.
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics.
Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum Capital Group are acting as co-managers.
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lyntris files for IPO, plans to list on NYSE under "LYNX"
- GoldInxs Mining Corp. completes IPO, lists on TSX Venture Exchange
- Reformation launches IPO on NYSE at $15-$17 per share
Create E-mail Alert Related Categories
IPOsRelated Entities
William Blair, Lazard, JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
